Letter to the Editor: Perspectives on the efficacy and biomarker exploration in neoadjuvant immunochemotherapy for NSCLC.

Int J Surg · 2025 · PMC12626463 · PMID 40679993

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Multivariate analysis identified tumor mutational burden (TMB) as the only independent predictor of pCR, whereas PD-L1 expression did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.